609 related articles for article (PubMed ID: 19457065)
21. In search of pathogenic amyloid β-peptide in familial Alzheimer's disease.
Wolfe MS
Prog Mol Biol Transl Sci; 2019; 168():71-78. PubMed ID: 31699328
[TBL] [Abstract][Full Text] [Related]
22. [New approaches for the development of anti-Alzheimer's disease drugs based on the cholinergic hypothesis and amyloid hypothesis].
Sugimoto H
Nihon Yakurigaku Zasshi; 2008 May; 131(5):338-40. PubMed ID: 18480562
[No Abstract] [Full Text] [Related]
23. Aging, amyloid, and Alzheimer's disease: a perspective in honor of Carl Cotman.
Selkoe DJ
Neurochem Res; 2003 Nov; 28(11):1705-13. PubMed ID: 14584824
[TBL] [Abstract][Full Text] [Related]
24. [Progress in the development of anti-amyloid drugs for treatment of Alzheimer's disease.].
Shitaka Y; Mitani Y; Nagakura A; Miyake A; Matsuoka N
Nihon Yakurigaku Zasshi; 2010 Jul; 136(1):15-20. PubMed ID: 20628208
[No Abstract] [Full Text] [Related]
25. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
Hardy J; Selkoe DJ
Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773
[TBL] [Abstract][Full Text] [Related]
26. Potential treatment opportunities for Alzheimer's disease through inhibition of secretases and Abeta immunization.
Schenk D; Games D; Seubert P
J Mol Neurosci; 2001 Oct; 17(2):259-67. PubMed ID: 11816797
[TBL] [Abstract][Full Text] [Related]
27. Recent approaches targeting beta-amyloid for therapeutic intervention of Alzheimer's disease.
Cho JE; Kim JR
Recent Pat CNS Drug Discov; 2011 Sep; 6(3):222-33. PubMed ID: 21834780
[TBL] [Abstract][Full Text] [Related]
28. AD vaccines: conclusions and future directions.
Wisniewski T
CNS Neurol Disord Drug Targets; 2009 Apr; 8(2):160-6. PubMed ID: 19355935
[No Abstract] [Full Text] [Related]
29. Cerebrovascular damage as a cause for Alzheimer's disease.
Humpel C; Marksteiner J
Curr Neurovasc Res; 2005 Oct; 2(4):341-7. PubMed ID: 16181125
[TBL] [Abstract][Full Text] [Related]
30. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective.
Tanzi RE; Bertram L
Cell; 2005 Feb; 120(4):545-55. PubMed ID: 15734686
[TBL] [Abstract][Full Text] [Related]
31. The amyloid precursor protein (APP) processing as a biological link between Alzheimer's disease and cancer.
Galvão F; Grokoski KC; da Silva BB; Lamers ML; Siqueira IR
Ageing Res Rev; 2019 Jan; 49():83-91. PubMed ID: 30500566
[TBL] [Abstract][Full Text] [Related]
32. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J
eNeuro; 2017; 4(2):. PubMed ID: 28374012
[TBL] [Abstract][Full Text] [Related]
33. Resveratrol and Alzheimer's disease. From molecular pathophysiology to clinical trials.
Drygalski K; Fereniec E; Koryciński K; Chomentowski A; Kiełczewska A; Odrzygóźdź C; Modzelewska B
Exp Gerontol; 2018 Nov; 113():36-47. PubMed ID: 30266470
[No Abstract] [Full Text] [Related]
34. Nanoparticle-chelator conjugates as inhibitors of amyloid-beta aggregation and neurotoxicity: a novel therapeutic approach for Alzheimer disease.
Liu G; Men P; Kudo W; Perry G; Smith MA
Neurosci Lett; 2009 May; 455(3):187-90. PubMed ID: 19429118
[TBL] [Abstract][Full Text] [Related]
35. [The mechanism of A beta production and its inhibition as a therapeutic strategy for the prevention of Alzheimer's disease].
Iwatsubo T
Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):30P-33P. PubMed ID: 12491772
[TBL] [Abstract][Full Text] [Related]
36. [Alzheimer's disease--an amyloid disease of the brain].
Nordstedt C; Lake S; Winblad B
Lakartidningen; 1992 Dec; 89(49):4255-60. PubMed ID: 1461050
[TBL] [Abstract][Full Text] [Related]
37. New therapies. New Alzheimer's treatments that may ease the mind.
Helmuth L
Science; 2002 Aug; 297(5585):1260-2. PubMed ID: 12193764
[No Abstract] [Full Text] [Related]
38. Amyloid, presenilins, and Alzheimer's disease.
Van Gassen G; Annaert W
Neuroscientist; 2003 Apr; 9(2):117-26. PubMed ID: 12708616
[TBL] [Abstract][Full Text] [Related]
39. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.
Barage SH; Sonawane KD
Neuropeptides; 2015 Aug; 52():1-18. PubMed ID: 26149638
[TBL] [Abstract][Full Text] [Related]
40. Mitochondrial translocation of amyloid precursor protein and its cleaved products: relevance to mitochondrial dysfunction in Alzheimer's disease.
Anandatheerthavarada HK; Devi L
Rev Neurosci; 2007; 18(5):343-54. PubMed ID: 19544621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
